Tag Archives: jefferson college of population health

The Population Health Colloquium: Social Determinants of Health, Precision Medicine and the Triple Aim

By Fred Goldstein, MS and Gregg Masters, MPH*

The field of population health continues to grow and create new areas of exploration and integration. Population health practitioners are called upon to play a central role as health systems, health plans or healthcare organizations work to implement their strategies designed to improve health care quality, access, outcomes and cost while weaning the US Healthcare system away from its fee-for-service reimbursement paradigm.

From the emerging recognition that Precision Medicine is not antithetical to population health, to the development of unique approaches to address the social determinants of health, it’s an exciting time.

This year’s agenda for the Population Health Colloquium reflects the dynamic nature of the field, featuring leading healthcare experts from academia, healthcare systems, health plans, data and analytics companies, population health companies, regulators, innovators and entrepreneurs. To add to the excitement, the $100,000 Hearst Health Prize will be awarded to one of three deserving finalists: the University of Arkansas Arkansas SAVES program; the Mental Health Outreach for Mothers (MOMS) Program; and the Sharp Transitions Program.

A range of value-based care and alternative payment models are being implemented across the U.S. healthcare landscape, and will be covered in depth at the Colloquium with presentations on ‘Are Alternative Payment Models Working?’ presented by Lawton R. Burns, PhD, MBA, Director of the Wharton Center for Healthcare Management and Economics and the James Joo-Jin Kim Professor of Health Care Management, Wharton School, University of Pennsylvania, and François de Brantes, MBA, Senior Vice President of Commercial Business Development, Remedy Partners. There will also be a number of ‘mini-summits‘ addressing value-based care and alternative payment models in different contexts and settings (orthopedic bundle, collaborative care, chronic conditions, patient engagement, and elder care).

The move to alternative sites of care will be covered in ‘Evolving Care Outside the Hospital to Meet Consumers Where They Are’, presented by Niki Buchanan, MA, PHM, General Manager, Philips PHM, and Shauna Coyne, Director of Innovations, New York-Presbyterian Hospital.

A Special Dinner Program (Tuesday, March 19), download brochure here.

Cells Are the New Cure: Advances in Precision Medicine‘ will focus on innovations, science, technology and medicine and explore the advances in precision medicine that are providing pathways to cures using human cells. The Panel will include, Richard M. Cohen Journalist, News Producer, “Dr. Max” Gomez, PhD, an Emmy-Award Winning Medical Correspondent, Robin L. Smith, MD, MBA, President and Chairman, Cura Foundation, and Meredith Vieira, Emmy Award-winning TV Journalist; Host, Executive Producer and Anchor.  Attendees at this event will each receive a copy of ‘Cells are the New Cure’ by Robin Smith, MD, MBA and “Dr. Max” Gomez, PhD and ‘Chasing Hope’ by Richard M. Cohen.

Join us on PopHealth Week, Wednesday, March 6th, as we chat with co-authors Max Gomez, PhD, and Robin L. Smith, MD, MBA to preview the principal message featured in their book including implications for population health management.

A major focus of the final day will be looking at the healthcare system itself, discussing what’s wrong and how we (including healthcare consumers) can fix it. Presentations will be given by Robert Pearl, MD, Contributor, Forbes; Professor, Stanford University School of Medicine, author of ‘Mistreated: Why We Think We’re Getting Good Health Care — and Why We’re Usually Wrong, Elisabeth Rosenthal, MD, Editor-in-Chief, Kaiser Health News, author of ‘An American Sickness: How Healthcare Became Big Business and How You Can Take It Back and Archelle Georgiou, MD, President, Georgiou Consulting; Author and Consumer Advocate, author of ‘Healthcare Choices: 5 Steps to Getting the Medical Care You Want and Need.

To conclude the Colloquium, the ever popular Health Leaders Panel will be moderated by Dr. Nash. This year’s line-up includes Mandy Mangat, MD, MPH, Chief Medical Officer, Navvis Healthcare; David Nace, MD, Chief Medical Officer, Innovaccer; Rita Numerof, PhD, President, Numerof & Associates, Inc.; and Gary A. Puckrein, PhD, President and Chief Executive Officer of the National Minority Quality Forum.

And that’s only a peek at some of the timely presentations, panels and mini-summits at this year’s Colloquium. If you haven’t registered yet, (more information here), there’s still time to block your schedule, secure your travel arrangements and come to the best Population Health Conference of the year,  March 18-20th at the Loews Philadelphia Hotel, in the City of Brotherly Love.

Still on the fence?, check out this invitation to the Colloquium via David B. Nash, MD, MBA, Dean, Jefferson College of Population Health, and our last chat with Dr. Nash, inAccelerating toward “Value Based Care”…or, “No Outcome, No Income”.’

We hope to see you there!


* Post sponsored by the Jefferson College of Population Health

Accelerating toward “Value Based Care”…or, “No Outcome, No Income”

By Gregg Masters, MPH and Fred Goldstein, MS

The concept of ‘managed healthcare’ has been part of the health policy lexicon in one way or another for decades, and has been variably embraced and scorned by different stakeholders.  Now that costs have reached unsustainable highs and life expectancy for Americans is on the decline, we’ve finally begun exploring ways to move from a ‘sick care model’ to one that values the health of the individual and the community.

Individuals point to the legacy U.S. fee-for-service payment model as either the inflationary culprit of a cost prohibitive, often inaccessible healthcare delivery system with wide variations in both quality and outcomes, or conversely, as the ‘strong medicine’ our challenged ‘health system’ requires. U.S. healthcare per capita spending is at a 2-5x that of its international peers (developed nations in the OECD) since it’s fueled by a set of incentives that encourage healthcare providers to ‘do more, to earn more’.

Our industry remains challenged to transform its care delivery model to enable the system to consistently deliver high quality care at reasonable price points both the end user (patient or consumer) or third party payer deem to be ‘fair value’ or reasonable.

Robust conversations in board rooms of major healthcare organizations have focused on the impact of the social determinants of health – non-clinical concerns (food and housing insecurity, poverty, education and employment) – on health status, have leaders beginning to direct their focus outward in an effort to understand how health care delivery must change to meet these critical needs. 

It’s generally acknowledged that when payment is ‘episodic’ in nature (fee-for-services) we incentivize a sick care model that merely treats symptoms without impacting overall health. When we examine health from a population-level perspective, we are able to address health maintenance or promotion at the individual or community level, by putting a spotlight on the causes of the underlying presenting ‘dis-ease’.

Both Government and the private sector are actively looking to transfer risk via a range of payment models from capitation to bundles, to all-inclusive population-based payments. However, their uptake has been slow, spotty and has met with variable degrees of success. Yet, all are organically converging under a ‘population health’ perspective or frame of mind.

Conceptually, a ‘population health’ approach makes enormous sense.  Because it typically involves connecting with stakeholders and organizations outside the healthcare delivery system, successful implementation often presents with significant challenges. The ‘how to’ is often disguised in myriad choices not easy to discern, differentially evaluate, and fund.

By all appearances, the move away from fee-for-service medicine to value based healthcare is accelerating.  Underlying this change is the not insignificant question of how one successfully completes the transition to the new paradigm while maintaining care quality and financial margins.

Some have downplayed the impact of population health…or positioned it in opposition to another high priority theme for healthcare leaders, i.e., precision medicine.  Yet, it is, in fact, the framework for success. Understanding the specific characteristics of the target population is the open window into the risk, outcomes and costs associated with the group, and the best way to truly measure one’s impact over time. Did the health of the group of persons we served improve overall?

There is good news for those who view precision medicine and targeting individuals as the ideal approach; in fact, the two actually can co-exist. Assessment and stratification, resulting in an intervention(s) to the individual are key characteristics of both precision medicine and population health frameworks. The introduction of genomics, proteomics and other more “individualized” assessment measures allows for a more precise determination of risk, stratification and selection of the appropriate intervention(s). 

None of this is easy, but it is necessary if we are to improve the health of our nation’s citizens in a financially responsible way. Social determinants of health play an oversized role in health status, and in order to address them effectively, we must undertake new approaches and thinking, working in broader coalitions and collaborative community partnerships.

Enter the Population Health Colloquium

Jefferson College of Population Health opened a decade ago, under the direction and guidance of its Founding Dean, David B. Nash, MD, MBA, as the first institution dedicated to the study of population health. Since 2008, it has been adding value via research, empirically demonstrated best practices and stewarding the training of the practitioners equipped to connect health with healthcare delivery.

In its 19th iteration, the Colloquium is an immersive experience that brings together thought leaders, innovators and entrepreneurs across the care continuum, including health policy wonks and regulators, to network and learn from one another.

Dr. Nash extends his invitation to the community in the video below:

This Wednesday, February 6th at on PopHealth Week, Dr. Nash chats with Niki Buchanan, Population Health Management Lead at Philips Wellcentive.

For more information on the 19th Population Health Colloquium including keynote faculty and the program agenda, including the Hearst Health Prize, click here.

See you in Philly!

Population Health and those ‘White Waters’ of Health Reform

By Fred Goldstein, MS and Gregg A. Masters, MPH

President Trump recently conceded the ‘repeal and replace‘ agenda of the Republican Party to reverse the Affordable Care Act (ACA) is:

Unbelievably Complex…’

Some may argue that those who are awakening to this perhaps unique ‘complexity’ is the POTUS himself and a majority of his anti-Obamacare Republican colleagues. For example, in August of 2009 Gregg Masters penned the following post in the run up to the ACA’s eventual passage: Health Reform 101 – ‘None of the Ransomed Knew How Deep Were the Waters Crossed!’ wherein he opined on its historically change resistant complexity given the intersection of opposing health policy ideologies:

‘The [health reform] oxygen (or change imperative ‘momo’) is gone, and the business owner of the reform narrative is desperately flailing for air. What was once seemingly brilliant political positioning, i.e., ‘you (the Congress) give me something I can sign into law’, now appears to have degraded into a desperate ‘chicken dance’ in search of a tangible face saving political accommodation.’

While others may suggest we haven’t come very far and that we’re still searching for the elusive ‘political accommodation‘ see: ‘House Republicans release long-awaited plan to repeal and replace Obamacare.

Amidst these shifting sands of health reform uncertainty, one of the ‘go-to’ conferences of the year to make sense of the likely vector of U.S. Health Policy is the Population Health Colloquium.

The Colloquium runs from March 27th – 29th in the ‘City of Brotherly Love‘ Philadelphia.  In its 17th year and masterfully curated and moderated by David Nash, MD, MBA the founding and current Dean of the College of Population Health at Jefferson University, the program brings together thought leaders, academics, practitioners and ‘best in class‘ operators in the population health industry. Covering the diverse population health ecosystem, the Colloquium will appeal to health system leadership, the payer community, clinicians, academics and both supplier and vendor stakeholder interests supporting the technology and infrastructure needs of an evolving industry and the networking opportunities may be unparalleled.

The Colloquium hashtag is #pophealth17, and digital dashboard, here – where you can pull both transcripts and analytics (after free registration).

This year’s event features keynotes ranging from the Future of Managed Care to Good Health is Good Business: The Results of an Innovative Alignment with Physicians and Communities.

Here are just a few of the many thought leaders and innovators providing keynotes this year include:

  • Stephen K. Klasko, MD, MBA
    President and Chief Executive Officer, Thomas Jefferson University and Jefferson Health, Philadelphia, PA
  • Marilyn Tavenner
    Chief Executive Officer, America’s Health Insurance Plans, Former Administrator, Centers for Medicare and Medicaid Services, Former Virginia Secretary of Health and Human Resources, Washington, DC
  • Lisa Simpson, MB, BCh, MPH, FAAP
    President and Chief Executive Officer, AcademyHealth, Deputy Director of the Agency for Healthcare Research and Quality, Washington, DC
  • Joseph F. Coughlin, PhD
    Founder and Director, MIT AgeLab, Massachusetts Institute of Technology, Cambridge, MA
  • Allison Brennan, MPP
    Vice President of Policy, National Association of ACOs, Washington, DC

The balance of keynotes can be found on the program Agenda. The range and the diversity of topics covered is impressive. For a representative sampling of interviews conducted at last year’s Colloquium, see: PHC 2016.

For an overview and update on the state of Population Health including an introduction and preview of the Population Health Colloquium 2017, we recently chatted with Dr. Nash:

Digging deeper into the Colloquium’s agenda we find ‘mini-summits‘ and ‘concurrent sessions’ on day two covering the following topics:

And concurrent sessions:

The most difficult part of this conference is deciding which sessions to attend. The complete agenda is available here, and a direct registration link for full details, here.

Also on Day two will be the awarding of the Hearst Health Prize For Excellence in Population Health now in its second year, this $100,000 prize goes to……..? Check out last year’s debrief of the winner ‘Community Care of North Carolina‘.

Tuesday evening closes with an optional dinner session, but one definitely worth attending to hear from Michael Dowling and Dr. Stephen Klasko on a panel moderated by David Nash MD, MBA.  This interesting and informative panel will discuss THE FUTURE OF CLINICALLY INTEGRATED NETWORKS a critically important component of creating a better health system and integrating population health.

So why come to the Colloquium? Hear and learn from true leaders, share your ideas and network. We can think of no better place to be March 27- 29 than Philadelphia…



Meet Jeffrey Rose, MD SVP Clinical Strategy @HearstHealth

by Gregg A. Masters, MPH

One of the many high quality healthcare or healthtech conferences we get to cover as Health Innovation Media, and their are a lot including HiMSS, TEDMED, Health 2.0, PHA Forum, ACO Congress, ACO Summit and the Health Datapalooza to name just a few, one of the most powerful is the Population Health Colloquium organized by David Nash, MD, MBA the Dean of the Jefferson College of Population Health.

In this sit down interview, my colleague and co-host Douglas Goldstein aka @eFuturist chats with Jeffrey Rose, MD, Senior Vice President for Clinical Strategy at Hearst Health (follow via @HearstHealth).

Enjoy the many insights proffered by this collegial exchange between two insightful thought leaders in the industry today!